Vendors must navigate varying national frameworks governing cold-chain handling, remote prescribing, patient verification, and pharmacovigilance, which increases operational complexity and cost
Retatrutide storage requirements Retatrutide is still in clinical trials and primarily available as a research compound
Studies show that up to 40% of weight lost on GLP-1 medications can be lean muscle mass if protein intake is insufficient
Future studies should continue to explore how nutrition quality, physical activity patterns, and muscle conservation affect outcomes in people using GLP-1 medications across different ages, genders, and health conditions (Kolli et al
[9] See also [edit] References [edit] 1 2 "Incretin hormones: Their role in health and disease"
The most common switch within the same drug class was seen among GLP-1 receptor agonists, specifically from liraglutide to semaglutide